131 related articles for article (PubMed ID: 28807821)
1. POPDC1 is suppressed in human breast cancer tissues and is negatively regulated by EGFR in breast cancer cell lines.
Amunjela JN; Tucker SJ
Cancer Lett; 2017 Oct; 406():81-92. PubMed ID: 28807821
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation.
Amunjela JN; Tucker SJ
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28954821
[TBL] [Abstract][Full Text] [Related]
3. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
[TBL] [Abstract][Full Text] [Related]
4. POPDC proteins as potential novel therapeutic targets in cancer.
Amunjela JN; Tucker SJ
Drug Discov Today; 2016 Dec; 21(12):1920-1927. PubMed ID: 27458118
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Popeye Domain Containing Gene Family in Organ Homeostasis.
Amunjela JN; Swan AH; Brand T
Cells; 2019 Dec; 8(12):. PubMed ID: 31817925
[TBL] [Abstract][Full Text] [Related]
6. Myoferlin is a key regulator of EGFR activity in breast cancer.
Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
[TBL] [Abstract][Full Text] [Related]
7. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
8. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.
Feng L; Huang S; An G; Wang G; Gu S; Zhao X
Int J Oncol; 2019 Nov; 55(5):1003-1018. PubMed ID: 31545416
[TBL] [Abstract][Full Text] [Related]
9. Popeye domain-containing 1 is down-regulated in failing human hearts.
Gingold-Belfer R; Bergman M; Alcalay Y; Schlesinger H; Aravot D; Berman M; Salman H; Brand T; Kessler-Icekson G
Int J Mol Med; 2011 Jan; 27(1):25-31. PubMed ID: 21069264
[TBL] [Abstract][Full Text] [Related]
10. High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes.
Chang HY; Tseng YK; Chen YC; Shu CW; Lin MI; Liou HH; Fu TY; Lin YC; Ger LP; Yeh MH; Liu PF
Surg Oncol; 2018 Jun; 27(2):314-320. PubMed ID: 29937187
[TBL] [Abstract][Full Text] [Related]
11. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
13. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
[TBL] [Abstract][Full Text] [Related]
14. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression.
Badra FA; Karamouzis MV; Ravazoula P; Likaki-Karatza E; Tzorakoleftherakis E; Koukouras D; Iconomou G; Xiros N; Siablis D; Papavassiliou AG; Kalofonos HP
Cancer Lett; 2006 Nov; 244(1):34-41. PubMed ID: 16517064
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Sushi Domain- Containing Protein 3 (SUSD3) and Insulin-like Growth Factor-I Receptor (IGF-IR) in Breast Cancer.
Zhao S; Chen SS; Gu Y; Jiang EZ; Yu ZH
Asian Pac J Cancer Prev; 2015; 16(18):8633-6. PubMed ID: 26745129
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
17. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
[TBL] [Abstract][Full Text] [Related]
18. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
19. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
